Atrial Appendage Occluder Market Outlook (2023 to 2033)

The atrial appendage occluder market size is projected to be valued at US$ 983.5 million in 2023 and is expected to rise to US$ 8193.0 million by 2033. The sales of atrial appendage occluders are projected to expand at a significant CAGR of 23.6% during the forecast period.

The atrial appendage, better described as the left atrial appendage (LAA) is an ear-shaped pouch present in the top left chamber of the human heart (Left Atrium). The functional significance of this structure is unknown. In patients living with arrhythmic cardiovascular conditions such as atrial fibrillation, blood accumulates in the left atrial appendage and can cause clotting of blood.

The blood clots can cause fatal strokes when pumped into the blood vessels. Along with oral anticoagulants, occlusion of LAA by an occluder is an alternative approach to protect cardiovascular patients from strokes and other complications. An atrial appendage occluder is thus a kind of plug that permanently closes the appendage.

According to a study published in the journal, Clinical Medical Insights, Cardiology, atrial fibrillation affects around 2 percent of the global population and the prevalence of the disease is expected to increase five times over the next four decades, especially in the United States, owing to the expanding elderly population base.

Attributes Details
Atrial Appendage Occluder Market Estimated Size (2023) US$ 983.5 million
Atrial Appendage Occluder Market CAGR (2023 to 2033) 23.6%
Atrial Appendage Occluder Market Forecasted Size (2033) US$ 8193.0 million

Don't pay for what you don't need

Customize your report by selecting specific countries or regions and save 30%!

Atrial Appendage Occluder Market Demand Analysis (2018 to 2022) Vs Market Outlook (2023 to 2033)

The global demand for atrial appendage occluders is projected to rise at a CAGR of 23.6% during the forecast period between 2023 and 2033, reaching a total of US$ 8193.0 million in 2033, according to a report from Future Market Insights (FMI). From 2018 to 2022, sales witnessed significant growth, registering a CAGR of 8.5%.

The increasing number of cardiovascular patients suffering from atrial fibrillation and thromboembolism is the primary factor contributing to market growth. Further, people's changing lifestyles, as well as the growing number of people suffering from obesity, diabetes, and hypertension, are increasing demand for the devices, contributing to market growth.

In the upcoming years, atrial appendage occluder market systems are expected to gain prominence as many new construction sites are already installing the same as a necessity. With the construction industry developing significantly in emerging regions, the demand for the Atrial appendage occluder market is expected to rise.

Certain factors, such as the limited use of the LAA occluder for patients who have a high risk of bleeding as well as stroke while on anticoagulant therapy, are limiting the market's growth. A few more factors limiting market growth include unfavorable policies and complications associated with surgery.

Which Are Some Prominent Drivers of the Atrial Appendage Occluder Market?

Growing Number of Cardiovascular Patients to Push Sales

The surging number of cardiovascular patients diagnosed with thromboembolism and atrial fibrillation worldwide is a key driver to the growth of the global atrial appendage occluder market. In addition, sedentary lifestyles and ailments like diabetes, obesity, and hypertension are also going to drive demand for such devices, paving the way for market expansion.

The global atrial appendage occluder market is extremely concentrated, with only a few players. Annually, roughly 15 million strokes occur worldwide, according to the World Health Organization (WHO). In 2010, the United States spent around US$ 53.9 billion on health care services, and drugs, and lost work days due to a heart stroke.

Ischemic strokes account for almost 87% of all strokes, which occur when blood circulation to the brain is compromised. Stroke is third among the main causes of mortality, and it is also the leading cause of long-term disability. Around 20% of ischemic strokes are caused by atrial fibrillation. All of these factors are catalyzing the growth of the atrial occluder market.

Sabyasachi Ghosh
Sabyasachi Ghosh

Principal Consultant

Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

What are the Challenges Faced by the Atrial Appendage Occluder Market?

Restricted Use of LAA Occluder to Stifle the Market Growth

The restricted use of LAA occluder solely for those at high risk of stroke and bleeding while on anticoagulant medication may limit market expansion. Furthermore, difficulties associated with device implantation and removal, such as tissue erosion, which might necessitate open heart surgery, may function as a limiting factor for market expansion. Also, unfavorable policies concerning endocardial LAA closure are likely to hamper market expansion.

Comparative View of the Atrial Appendage Occluder Market

Atrial Appendage Occluder Market

Attributes Atrial Appendage Occluder Market
CAGR (2023 to 2033) 23.6%
Market Value (2033) US$ 8193.0 million
Growth Factor The surging number of cardiovascular patients diagnosed with thromboembolism and atrial fibrillation worldwide is a key driver to the growth of the global atrial appendage occluder market.
Opportunity Sedentary lifestyles and ailments like diabetes, obesity, and hypertension are likely to drive demand for such devices, paving the way for market expansion.
Key Trends The demand for the atrial appendage occluder market is expected to rise due to the construction industry developing significantly in emerging regions.

Amblyopia Treatment Market

Attributes Amblyopia Treatment Market
CAGR (2023 to 2033) 3.8%
Market Value (2033) US$ 5,582.3 million
Growth Factor The growing prevalence of hypermetropia and myopia across the globe is expected to play a key role in driving the market during the forecast period.
Opportunity Players are adopting various innovative methods to advance the treatment method which is projected to offer remunerative opportunities to the industry in the forthcoming time.
Key Trends Increasing focus on technological development for advanced products in the amblyopia treatment market is likely to offer significant opportunities to the market in the forthcoming period.

Osteonecrosis Treatment Market

Attributes Osteonecrosis Treatment Market
CAGR (2023 to 2033) 4.9%
Market Value (2033) US$ 434.0 million
Growth Factor The increasing geriatric population is leading to a rise in hip injuries and this is promoting the market during the forecast period.
Opportunity The market opportunities might surge owing to several research and development activities for developing novel drugs.
Key Trends The demand is said to escalate due to rising awareness about non-invasive methods of osteonecrosis treatment.

Get the data you need at a Fraction of the cost

Personalize your report by choosing insights you need
and save 40%!

Category-wise Insights of Atrial Appendage Occluder

Which Procedure of Positioning the Device is Leading in the Global Atrial Appendage Occluder Market?

The Endocardial Segment is to have the Highest Demand

The endocardial segment is anticipated to have a high market share of 87.20% because they are both safe and effective. Further, several clinical studies on endocardial devices have yielded encouraging results for the patient population in terms of stroke risk reduction, contributing to the segment's market share.

The endocardial segment is likely to have a low complication rate (around 8.5%) than the Epicardial (25.4%), which is believed to drive segment growth. In addition, Epicardial has emerged as an alternative procedure for LAA closures to improve efficacy, especially in patients who have had poor results with the standard endocardial technique.

The Epicardial segment is forecasted to account for 15% of the global atrial appendage occluder market share during the forecast period.

Which End-Use Segment is Likely to Contribute Most to the Global Atrial Appendage Occluder Market?

Hospital Segment to be the Dominant Segment Acquiring 63.20% Value Share

The hospital segment of the atrial appendage occluder market is anticipated to expand notably. The growing number of hospitals and the advancement of infrastructure are expected to drive demand for the devices.

According to the Centres for Medicare and Medicaid Services, the United States spent almost 3.6 trillion US$ on healthcare management in 2018. This is expected to boost the market for atrial appendage occluder. Furthermore, the rising prevalence of atrial fibrillation is expected to play a significant role in this segment. Atrial fibrillation is one of the most common heart conditions, according to the European Society of Cardiology.

The prevalence of atrial fibrillation in people aged 65 and older was around 7.6 million in 2016, and it is expected to rise by 89%, to around 14 million by 2060. Hence, the aforementioned factors are expected to increase hospital visits for atrial appendage management, increasing demand for atrial appendage occluder in this segment.

Regional Analysis of the Atrial Appendage Occluder Market

A Growing Geriatric Population Driving Demand for Atrial Appendage Occluders in North America?

As per FMI, North America is anticipated to dominate the atrial appendage occluders market during the forecast period. This is because of its vast geriatric population. Moreover, the region's huge population, which accounts for the high number of stroke deaths, is the primary cause for individuals depending on atrial appendage occluders, particularly in the United States. Thus, in 2022, North America held a market share of 39.8% for atrial appendage occluder.

Is the Increased Risk of Atrial Fibrillation Fueling Europe’s Market for Atrial Appendage Occluders?

Europe’s Sedentary Lifestyles Favoring Market Growth

According to a report published in the journal Indian Pacing and Electrophysiology Journal, Europe’s Atrial appendage occluder market is likely to rise since more than 6 million people in Europe are already living with arrhythmia, and the number is expected to double over the next 50 years. According to one study, the European race has a great incidence of atrial fibrillation than other races.

Sedentary lifestyles and the number of persons with cardiovascular problems are predicted to rise in developed nations, driving market development in the future. This, in turn, is projected to serve the atrial appendage occluder market development. As a result of the aforementioned factors, Europe held a market share of 27.3% in the atrial occluder market in 2022.

Competitive Landscape

Key players in the atrial appendage occluder market include Appriva Medical Inc., Boston Scientific, Abbott, SentreHEART Inc, and pfm Medical Ag. Occlutech, W. L. Gore & Associates, Coherex Medical, Inc., Cardia, Inc., and AtriCure, Inc. amongst others.

Key players focus on strategic formulations such as research collaborations, new product releases, market penetration, and distribution alliances for developing a commercial presence. Furthermore, these industry leaders are substantially spending on research activities, which encourage innovation and help them to commercialize improved products and maximize market income.

Recent Developments in the Atrial Appendage Occluder Market

In August 2022, Abbott and WW International, Inc. established a strategic alliance to assist people with diabetes to better understand and manage their diabetes and weight. The companies are collaborating to integrate WeightWatchers' diabetes-specific weight management program with Abbott's portfolio of FreeStyle Libre® products to create a seamless mobile experience that is going to provide people living with diabetes with information and insights.

Diabetic people can make healthy dietary adjustments, improve their glucose levels, and, ultimately, gain more control of their health through the information and insights provided.

  • In July 2022, DURAMESH Suturable Mesh is being added to the product portfolio of PFM Medical AG. For the first time. This novel suturable mesh combines the benefits of mesh repair with the precise application of surgical sutures. When large pressures must be imparted, DURAMESH can be used in place of surgical sutures.
  • In June 2022, Boston Scientific Corporation, announced that it has entered into a definitive agreement with Synergy Innovation Co., Ltd to acquire its majority stake in M.I.Tech Co., Ltd, a publicly traded Korean manufacturer and distributor of medical devices for endoscopic and urologic procedures. M.I.Tech invented the HANAROSTENTTM technology, a line of conformable, non-vascular, self-expanding metal stents supplied in Japan by Boston Scientific since 2015. The acquisition price is KRW 14,500 per share, for a total of KRW 291.2 billion, or roughly US$ 230 million at current exchange rates, subject to closing adjustments.

Scope of the Report

Attribute Details
Growth Rate CAGR of 23.6% from 2023 to 2033
Base Year of Estimation 2023
Historical Data 2018 to 2022
Forecast Period 2023 to 2033
Quantitative Units Revenue in US$ billion and Volume in Units and F-CAGR from 2022-2032
Report Coverage Revenue Forecast, Volume Forecast, Company Ranking, Competitive Landscape, growth factors, Trends, and Pricing Analysis
Key Segments Covered Type of Indication, Positioning of Device, End User, By Region
Regions Covered North America; Latin America; Europe; East Asia; South Asia; The Middle East & Africa; Oceania
Key Countries Profiled The United States, Canada, Brazil, Mexico, Germany, Italy, France, The United Kingdom, Spain, Russia, China, Japan, India, GCC Countries, Australia
Key Companies Profiled Appriva Medical Inc.; Boston Scientific; Abbott; SentreHEART Inc; pfm medical ag.; Occlutech; W. L. Gore & Associates; Coherex Medical, Inc.; Cardia, Inc.; AtriCure, Inc.
Customization & Pricing Available upon Request

Key Segments Covered in the Atrial Appendage Occluder Market Report

By Type of indication:

  • Non-valvular Atrial Fibrillation

The Procedure of Positioning of the Device:

  • Endocardial
  • Epicardial

By End-user:

  • Hospitals
  • Clinics

By Region

  • North America
  • Latin America
  • Western Europe
  • Eastern Europe
  • Asia Pacific Excluding Japan (APEJ)
  • Japan
  • The Middle East & Africa (MEA)

Frequently Asked Questions

What is the Estimated Atrial Appendage Occluder Market Value in 2023?

The global atrial appendage occluder market is estimated to be valued at US$ 983.5 million in 2023.

What is the Growth Outlook of the Global Atrial Appendage Occluder Market?

The atrial appendage occluder market is likely to thrive at a CAGR of 23.6% from 2023 to 2033.

What is the Projected Value of the Atrial Appendage Occluder Market by 2033?

The atrial appendage occluder market is projected to reach a valuation of US$ 8193.0 million by 2033.

Which Region Dominates the Global Atrial Appendage Occluder Market?

North America is projected to lead the global atrial appendage occluder market by 2033.

Table of Content

1. Executive Summary

    1.1. Global Market Outlook

    1.2. Demand-side Trends

    1.3. Supply-side Trends

    1.4. Technology Roadmap Analysis

    1.5. Analysis and Recommendations

2. Market Overview

    2.1. Market Coverage / Taxonomy

    2.2. Market Definition / Scope / Limitations

3. Market Background

    3.1. Market Dynamics

        3.1.1. Drivers

        3.1.2. Restraints

        3.1.3. Opportunity

        3.1.4. Trends

    3.2. Scenario Forecast

        3.2.1. Demand in Optimistic Scenario

        3.2.2. Demand in Likely Scenario

        3.2.3. Demand in Conservative Scenario

    3.3. Opportunity Map Analysis

    3.4. Investment Feasibility Matrix

    3.5. PESTLE and Porter’s Analysis

    3.6. Regulatory Landscape

        3.6.1. By Key Regions

        3.6.2. By Key Countries

    3.7. Regional Parent Market Outlook

4. Global Analysis 2018 to 2022 and Forecast, 2023 to 2033

    4.1. Historical Market Size Value (US$ Million) Analysis, 2018 to 2022

    4.2. Current and Future Market Size Value (US$ Million) Projections, 2023 to 2033

        4.2.1. Y-o-Y Growth Trend Analysis

        4.2.2. Absolute $ Opportunity Analysis

5. Global Analysis 2018 to 2022 and Forecast 2023 to 2033, By Type of indication

    5.1. Introduction / Key Findings

    5.2. Historical Market Size Value (US$ Million) Analysis By Type of indication, 2018 to 2022

    5.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Type of indication, 2023 to 2033

        5.3.1. Non-valvular Atrial Fibrillation

    5.4. Y-o-Y Growth Trend Analysis By Type of indication, 2018 to 2022

    5.5. Absolute $ Opportunity Analysis By Type of indication, 2023 to 2033

6. Global Analysis 2018 to 2022 and Forecast 2023 to 2033, By Procedure of positioning of the device

    6.1. Introduction / Key Findings

    6.2. Historical Market Size Value (US$ Million) Analysis By Procedure of positioning of the device, 2018 to 2022

    6.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Procedure of positioning of the device, 2023 to 2033

        6.3.1. Endocardial

        6.3.2. Epicardial

    6.4. Y-o-Y Growth Trend Analysis By Procedure of positioning of the device, 2018 to 2022

    6.5. Absolute $ Opportunity Analysis By Procedure of positioning of the device, 2023 to 2033

7. Global Analysis 2018 to 2022 and Forecast 2023 to 2033, By End user

    7.1. Introduction / Key Findings

    7.2. Historical Market Size Value (US$ Million) Analysis By End user , 2018 to 2022

    7.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By End user , 2023 to 2033

        7.3.1. Hospitals

        7.3.2. Clinics

    7.4. Y-o-Y Growth Trend Analysis By End user , 2018 to 2022

    7.5. Absolute $ Opportunity Analysis By End user , 2023 to 2033

8. Global Analysis 2018 to 2022 and Forecast 2023 to 2033, By Region

    8.1. Introduction

    8.2. Historical Market Size Value (US$ Million) Analysis By Region, 2018 to 2022

    8.3. Current Market Size Value (US$ Million) Analysis and Forecast By Region, 2023 to 2033

        8.3.1. North America

        8.3.2. Latin America

        8.3.3. Western Europe

        8.3.4. Eastern Europe

        8.3.5. South Asia and Pacific

        8.3.6. East Asia

        8.3.7. Middle East and Africa

    8.4. Market Attractiveness Analysis By Region

9. North America Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

    9.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022

    9.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033

        9.2.1. By Country

            9.2.1.1. U.S.

            9.2.1.2. Canada

        9.2.2. By Type of indication

        9.2.3. By Procedure of positioning of the device

        9.2.4. By End user

    9.3. Market Attractiveness Analysis

        9.3.1. By Country

        9.3.2. By Type of indication

        9.3.3. By Procedure of positioning of the device

        9.3.4. By End user

    9.4. Key Takeaways

10. Latin America Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

    10.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022

    10.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033

        10.2.1. By Country

            10.2.1.1. Brazil

            10.2.1.2. Mexico

            10.2.1.3. Rest of Latin America

        10.2.2. By Type of indication

        10.2.3. By Procedure of positioning of the device

        10.2.4. By End user

    10.3. Market Attractiveness Analysis

        10.3.1. By Country

        10.3.2. By Type of indication

        10.3.3. By Procedure of positioning of the device

        10.3.4. By End user

    10.4. Key Takeaways

11. Western Europe Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

    11.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022

    11.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033

        11.2.1. By Country

            11.2.1.1. Germany

            11.2.1.2. U.K.

            11.2.1.3. France

            11.2.1.4. Spain

            11.2.1.5. Italy

            11.2.1.6. Rest of Western Europe

        11.2.2. By Type of indication

        11.2.3. By Procedure of positioning of the device

        11.2.4. By End user

    11.3. Market Attractiveness Analysis

        11.3.1. By Country

        11.3.2. By Type of indication

        11.3.3. By Procedure of positioning of the device

        11.3.4. By End user

    11.4. Key Takeaways

12. Eastern Europe Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

    12.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022

    12.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033

        12.2.1. By Country

            12.2.1.1. Poland

            12.2.1.2. Russia

            12.2.1.3. Czech Republic

            12.2.1.4. Romania

            12.2.1.5. Rest of Eastern Europe

        12.2.2. By Type of indication

        12.2.3. By Procedure of positioning of the device

        12.2.4. By End user

    12.3. Market Attractiveness Analysis

        12.3.1. By Country

        12.3.2. By Type of indication

        12.3.3. By Procedure of positioning of the device

        12.3.4. By End user

    12.4. Key Takeaways

13. South Asia and Pacific Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

    13.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022

    13.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033

        13.2.1. By Country

            13.2.1.1. India

            13.2.1.2. Bangladesh

            13.2.1.3. Australia

            13.2.1.4. New Zealand

            13.2.1.5. Rest of South Asia and Pacific

        13.2.2. By Type of indication

        13.2.3. By Procedure of positioning of the device

        13.2.4. By End user

    13.3. Market Attractiveness Analysis

        13.3.1. By Country

        13.3.2. By Type of indication

        13.3.3. By Procedure of positioning of the device

        13.3.4. By End user

    13.4. Key Takeaways

14. East Asia Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

    14.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022

    14.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033

        14.2.1. By Country

            14.2.1.1. China

            14.2.1.2. Japan

            14.2.1.3. South Korea

        14.2.2. By Type of indication

        14.2.3. By Procedure of positioning of the device

        14.2.4. By End user

    14.3. Market Attractiveness Analysis

        14.3.1. By Country

        14.3.2. By Type of indication

        14.3.3. By Procedure of positioning of the device

        14.3.4. By End user

    14.4. Key Takeaways

15. Middle East and Africa Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

    15.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022

    15.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033

        15.2.1. By Country

            15.2.1.1. GCC Countries

            15.2.1.2. South Africa

            15.2.1.3. Israel

            15.2.1.4. Rest of MEA

        15.2.2. By Type of indication

        15.2.3. By Procedure of positioning of the device

        15.2.4. By End user

    15.3. Market Attractiveness Analysis

        15.3.1. By Country

        15.3.2. By Type of indication

        15.3.3. By Procedure of positioning of the device

        15.3.4. By End user

    15.4. Key Takeaways

16. Key Countries Analysis

    16.1. U.S.

        16.1.1. Pricing Analysis

        16.1.2. Market Share Analysis, 2022

            16.1.2.1. By Type of indication

            16.1.2.2. By Procedure of positioning of the device

            16.1.2.3. By End user

    16.2. Canada

        16.2.1. Pricing Analysis

        16.2.2. Market Share Analysis, 2022

            16.2.2.1. By Type of indication

            16.2.2.2. By Procedure of positioning of the device

            16.2.2.3. By End user

    16.3. Brazil

        16.3.1. Pricing Analysis

        16.3.2. Market Share Analysis, 2022

            16.3.2.1. By Type of indication

            16.3.2.2. By Procedure of positioning of the device

            16.3.2.3. By End user

    16.4. Mexico

        16.4.1. Pricing Analysis

        16.4.2. Market Share Analysis, 2022

            16.4.2.1. By Type of indication

            16.4.2.2. By Procedure of positioning of the device

            16.4.2.3. By End user

    16.5. Germany

        16.5.1. Pricing Analysis

        16.5.2. Market Share Analysis, 2022

            16.5.2.1. By Type of indication

            16.5.2.2. By Procedure of positioning of the device

            16.5.2.3. By End user

    16.6. U.K.

        16.6.1. Pricing Analysis

        16.6.2. Market Share Analysis, 2022

            16.6.2.1. By Type of indication

            16.6.2.2. By Procedure of positioning of the device

            16.6.2.3. By End user

    16.7. France

        16.7.1. Pricing Analysis

        16.7.2. Market Share Analysis, 2022

            16.7.2.1. By Type of indication

            16.7.2.2. By Procedure of positioning of the device

            16.7.2.3. By End user

    16.8. Spain

        16.8.1. Pricing Analysis

        16.8.2. Market Share Analysis, 2022

            16.8.2.1. By Type of indication

            16.8.2.2. By Procedure of positioning of the device

            16.8.2.3. By End user

    16.9. Italy

        16.9.1. Pricing Analysis

        16.9.2. Market Share Analysis, 2022

            16.9.2.1. By Type of indication

            16.9.2.2. By Procedure of positioning of the device

            16.9.2.3. By End user

    16.10. Poland

        16.10.1. Pricing Analysis

        16.10.2. Market Share Analysis, 2022

            16.10.2.1. By Type of indication

            16.10.2.2. By Procedure of positioning of the device

            16.10.2.3. By End user

    16.11. Russia

        16.11.1. Pricing Analysis

        16.11.2. Market Share Analysis, 2022

            16.11.2.1. By Type of indication

            16.11.2.2. By Procedure of positioning of the device

            16.11.2.3. By End user

    16.12. Czech Republic

        16.12.1. Pricing Analysis

        16.12.2. Market Share Analysis, 2022

            16.12.2.1. By Type of indication

            16.12.2.2. By Procedure of positioning of the device

            16.12.2.3. By End user

    16.13. Romania

        16.13.1. Pricing Analysis

        16.13.2. Market Share Analysis, 2022

            16.13.2.1. By Type of indication

            16.13.2.2. By Procedure of positioning of the device

            16.13.2.3. By End user

    16.14. India

        16.14.1. Pricing Analysis

        16.14.2. Market Share Analysis, 2022

            16.14.2.1. By Type of indication

            16.14.2.2. By Procedure of positioning of the device

            16.14.2.3. By End user

    16.15. Bangladesh

        16.15.1. Pricing Analysis

        16.15.2. Market Share Analysis, 2022

            16.15.2.1. By Type of indication

            16.15.2.2. By Procedure of positioning of the device

            16.15.2.3. By End user

    16.16. Australia

        16.16.1. Pricing Analysis

        16.16.2. Market Share Analysis, 2022

            16.16.2.1. By Type of indication

            16.16.2.2. By Procedure of positioning of the device

            16.16.2.3. By End user

    16.17. New Zealand

        16.17.1. Pricing Analysis

        16.17.2. Market Share Analysis, 2022

            16.17.2.1. By Type of indication

            16.17.2.2. By Procedure of positioning of the device

            16.17.2.3. By End user

    16.18. China

        16.18.1. Pricing Analysis

        16.18.2. Market Share Analysis, 2022

            16.18.2.1. By Type of indication

            16.18.2.2. By Procedure of positioning of the device

            16.18.2.3. By End user

    16.19. Japan

        16.19.1. Pricing Analysis

        16.19.2. Market Share Analysis, 2022

            16.19.2.1. By Type of indication

            16.19.2.2. By Procedure of positioning of the device

            16.19.2.3. By End user

    16.20. South Korea

        16.20.1. Pricing Analysis

        16.20.2. Market Share Analysis, 2022

            16.20.2.1. By Type of indication

            16.20.2.2. By Procedure of positioning of the device

            16.20.2.3. By End user

    16.21. GCC Countries

        16.21.1. Pricing Analysis

        16.21.2. Market Share Analysis, 2022

            16.21.2.1. By Type of indication

            16.21.2.2. By Procedure of positioning of the device

            16.21.2.3. By End user

    16.22. South Africa

        16.22.1. Pricing Analysis

        16.22.2. Market Share Analysis, 2022

            16.22.2.1. By Type of indication

            16.22.2.2. By Procedure of positioning of the device

            16.22.2.3. By End user

    16.23. Israel

        16.23.1. Pricing Analysis

        16.23.2. Market Share Analysis, 2022

            16.23.2.1. By Type of indication

            16.23.2.2. By Procedure of positioning of the device

            16.23.2.3. By End user

17. Market Structure Analysis

    17.1. Competition Dashboard

    17.2. Competition Benchmarking

    17.3. Market Share Analysis of Top Players

        17.3.1. By Regional

        17.3.2. By Type of indication

        17.3.3. By Procedure of positioning of the device

        17.3.4. By End user

18. Competition Analysis

    18.1. Competition Deep Dive

        18.1.1. Appriva Medical Inc.

            18.1.1.1. Overview

            18.1.1.2. Product Portfolio

            18.1.1.3. Profitability by Market Segments

            18.1.1.4. Sales Footprint

            18.1.1.5. Strategy Overview

                18.1.1.5.1. Marketing Strategy

        18.1.2. Boston Scientific

            18.1.2.1. Overview

            18.1.2.2. Product Portfolio

            18.1.2.3. Profitability by Market Segments

            18.1.2.4. Sales Footprint

            18.1.2.5. Strategy Overview

                18.1.2.5.1. Marketing Strategy

        18.1.3. Abbott

            18.1.3.1. Overview

            18.1.3.2. Product Portfolio

            18.1.3.3. Profitability by Market Segments

            18.1.3.4. Sales Footprint

            18.1.3.5. Strategy Overview

                18.1.3.5.1. Marketing Strategy

        18.1.4. SentreHEART Inc

            18.1.4.1. Overview

            18.1.4.2. Product Portfolio

            18.1.4.3. Profitability by Market Segments

            18.1.4.4. Sales Footprint

            18.1.4.5. Strategy Overview

                18.1.4.5.1. Marketing Strategy

        18.1.5. pfm medical ag.

            18.1.5.1. Overview

            18.1.5.2. Product Portfolio

            18.1.5.3. Profitability by Market Segments

            18.1.5.4. Sales Footprint

            18.1.5.5. Strategy Overview

                18.1.5.5.1. Marketing Strategy

        18.1.6. Occlutech

            18.1.6.1. Overview

            18.1.6.2. Product Portfolio

            18.1.6.3. Profitability by Market Segments

            18.1.6.4. Sales Footprint

            18.1.6.5. Strategy Overview

                18.1.6.5.1. Marketing Strategy

        18.1.7. W. L. Gore & Associates

            18.1.7.1. Overview

            18.1.7.2. Product Portfolio

            18.1.7.3. Profitability by Market Segments

            18.1.7.4. Sales Footprint

            18.1.7.5. Strategy Overview

                18.1.7.5.1. Marketing Strategy

        18.1.8. Coherex Medical, Inc.

            18.1.8.1. Overview

            18.1.8.2. Product Portfolio

            18.1.8.3. Profitability by Market Segments

            18.1.8.4. Sales Footprint

            18.1.8.5. Strategy Overview

                18.1.8.5.1. Marketing Strategy

        18.1.9. Cardia, Inc.

            18.1.9.1. Overview

            18.1.9.2. Product Portfolio

            18.1.9.3. Profitability by Market Segments

            18.1.9.4. Sales Footprint

            18.1.9.5. Strategy Overview

                18.1.9.5.1. Marketing Strategy

        18.1.10. AtriCure, Inc.

            18.1.10.1. Overview

            18.1.10.2. Product Portfolio

            18.1.10.3. Profitability by Market Segments

            18.1.10.4. Sales Footprint

            18.1.10.5. Strategy Overview

                18.1.10.5.1. Marketing Strategy

19. Assumptions & Acronyms Used

20. Research Methodology

Recommendations

Healthcare

Amblyopia Treatment Market

September 2017

REP-GB-5039

July 2023

306 pages

Healthcare

Atrial Fibrillation Device Market

November 2016

REP-GB-2214

May 2022

300 pages

Explore Healthcare Insights

View Reports
Future Market Insights

Atrial Appendage Occluder Market